Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

Blood or marrow transplantation survivors have higher risk of cognitive impairment

Blood or marrow transplantation survivors have higher risk of cognitive impairment

US-based clinical study highlights safety and effectiveness of MENTOR MemoryShape Gel Breast Implants

US-based clinical study highlights safety and effectiveness of MENTOR MemoryShape Gel Breast Implants

New guidelines offer recommendations for assessment, management of immunotherapy side effects

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Using Smartphones for Cancer Diagnosis and Management

Using Smartphones for Cancer Diagnosis and Management

Moffitt study identifies new drug target that may reduce GVHD risk

Moffitt study identifies new drug target that may reduce GVHD risk

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Scientists develop immune-stimulating injections against cancer

Scientists develop immune-stimulating injections against cancer

New modular platform offers robust biological approach that targets endless number of diseases

New modular platform offers robust biological approach that targets endless number of diseases

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

Scientists discover the genetic cause of immune disorders

Scientists discover the genetic cause of immune disorders

New discovery sheds light on iron-restricted anemia that causes fatigue in millions

New discovery sheds light on iron-restricted anemia that causes fatigue in millions

New biomaterials-based system improves T-cell production

New biomaterials-based system improves T-cell production

Researchers use immune-mimicking biomaterial scaffolds to fast track T cell therapies

Researchers use immune-mimicking biomaterial scaffolds to fast track T cell therapies

Researchers create ‘protocells’ for delivering drugs to deepest tumor regions

Researchers create ‘protocells’ for delivering drugs to deepest tumor regions

Clinical benefit of new cancer therapies may justify the expensive price

Clinical benefit of new cancer therapies may justify the expensive price

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Mayo Clinic study: Increasing physical activity decreases risk of death from lymphoma

Mayo Clinic study: Increasing physical activity decreases risk of death from lymphoma

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Caris Life Sciences reveals identification of new mechanism of action to treat NHL